LEI Uptake Still Brisk Post-Mifid II Deadline

The lead-up to Mifid II led to a huge jump in Legal Entity Identifiers issued, and LEI uptake continues to break records through Q1 2018.

stephan wolf GLEIF
Stephan Wolf, GLEIF CEO: "We expect regulatory action to remain one of the drivers of global LEI adoption"

According to the Global Legal Entity Identifier Foundation (GLEIF), although the Mifid II preparation frenzy is over, the LEI bacchanalia carries on.

GLEIF CEO Stephan Wolf reports that to date, LEI issuance for 2018 “significantly exceeded historic data,” with about 168,000 LEIs issued in the first quarter, compared to 19,000 issued in the first quarter of 2017.

In December of 2017, the European Securities and Markets Authority (Esma) granted market participants a six-month grace period to

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Register for free

Access two articles, our IMD and Waters Wraps, plus a member newsletter. Find out more.

All fields are mandatory unless otherwise highlighted.

Back to basics: Taxonomies, lineage still stifle data efforts

Voice of the CDO: While data professionals are increasingly showing their value when it comes to analytics and AI adoption, their main job is still—crucially—getting a strong data foundation in place. That starts with taxonomies and lineage.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here